Screener
Novavax NVAX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Novavax’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001000694-26-000018
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Inventory | 10,006 | 11,545 |
| Prepaid expenses and other current assets | 23,013 | 26,815 |
| Assets held for sale | — | 87,510 |
| Total current assets | 771,098 | 978,276 |
| Property and equipment, net | 38,133 | 44,800 |
| Right-of-use asset, net | 19,842 | 22,897 |
| Goodwill | 112,542 | 113,462 |
| Other non-current assets | 13,960 | 17,077 |
Item 1. Consolidated Financial Statements
FAQ
- What is Novavax's total current assets?
- Novavax (NVAX) reported total current assets of $771.1M in Q2 2026.
- How has Novavax's total current assets changed year-over-year?
- Novavax's total current assets decreased by 16.1% year-over-year, from $919.51M to $771.1M.
- What is the long-term trend for Novavax's total current assets?
- Over 5 years (2020 to 2025), Novavax's total current assets has grown at a -4.8% compound annual growth rate (CAGR), from $1.25B to $978.28M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Novavax's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude